Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-03-22
2005-03-22
Jones, W. Gary (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C530S350000, C435S006120, C435S007100
Reexamination Certificate
active
06870037
ABSTRACT:
Disclosed are novel nucleic acid and peptide compositions comprising methythlioadenosine phosphorylase (MTAP) and methods of use for MTAP amino acid sequences and DNA segments comprising MTAP in the diagnosis of human cancers and development of MTAP-specific antibodies. Also disclosed are methods for the diagnosis and treatment of tumors and other proliferative cell disorders, and idenification tumor suppressor genes and gene products from the human 9p21-p22 chromosome region. Such methods are useful in the diagnosis of multiple tumor types such as bladder cancer, lung cancer, breast cancer, pancreatic cancer, brain tumors, lymphomas, gliomas, melanomas, and leukemias.
REFERENCES:
Arap, Nishikawa, Furnari, Cavenee, and Huang, “Replacement of the p16/CDKN2 Gene Suppresses Human Glioma Cell Growth,”Cancer Research, 55:1351-1354, Mar., 1995.
Bohlander, Dreyling, Hagos, Sveen, Olopade, and Diaz, “Mapping a Putative Tumor Suppressor Gene on Chromosome 9 Bands p21-p22 with Microdissection Probes,”Genomics, 24:211-217, 1994.
Bohlander, Espinosa III, Le Beau, Rowley, and Diaz, “A Method for the Rapid Sequence-Independent Amplification of Microdissected Chromosomal Material,”Genomics, 13:1322-1324, 1992.
Chen, Zhang, and Savarese, “Gene Deletion Chemoselectivity: Codeletion of the Genes for p16INK4, Methylthioadenosine Phosphorylase, and the α- and β-Interferons in Human Pancreatic Cell Carcinoma Lines and Its Implications for Chemotherapy,”Cancer Research, 56:1083-1090, Mar., 1996.
Cheng, Jhanwar, Klein, Bell, Lee, Altomare, Nobori, Olopade, Buckler, and Testa, “p16 Alterations and Deletion Mapping of 9p21-p22 in Malignant Mesothelioma,”Cancer Research, 54:5547-5551, Nov., 1994.
Dreyling, Bohlander, Adeyanju, and Olopade, “Detection of CDKN2 Deletions in Tumor Cell Lines and Primary Glioma by Interphase Fluorescence in Situ Hybridization,”Cancer Research, 55:984-988, Mar., 1995.
Dreyling, Olopade, and Bohlander, “Detection of Deletion of the Tumor Suppressor Region on 9p21 in Acute Leukemia by Fluorescence in Situ Hybridization to Interphase Nuclei,”Blood(Abstract #1176), p. 298a, 1995.
Dreyling, Olopade, and Bohlander, “A method for screening arrayed cosmid libraries with mega insert yeast artificial chromosomes,”Nucleic Acids Research, 23(6):1085-1086, 1995.
Hebert, Cayuela, Berkeley, and Sigaux, “Candidate Tumor-Suppressor Genes MTS1 (p16INK4A) and MTS2 (p15INK4B) Display Frequent Homozygous Deletions in Primary Cells From T- But Not From B-Cell Lineage Acute Lymphoblastic Leukemias,”Blood, 84(12):4038-4044, Dec., 1994.
Hussussian, Struewing, Goldstein, Higgins, Ally, Sheahan, Clark Jr., Tucker, and Dracopoli, “Germline p16 mutations in familial melanoma,”Nature Genetics, 8:15-21, Sep., 1994.
Kamatani, Nelson-Rees, and Carson, “Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme,”Proc. Natl. Acad. Sci. USA, 78(2):1219-1223, Feb., 1981.
Kamb, Shattuck-Eidens, Eeles, Liu, Gruis, Ding, Hussey, Tran, Miki, Weaver-Feldhaus, McClure, Aitken, Anderson, Bergman, Frants, Goldgar, Green, MacLennan, Martin, Meyer, Youl, Zone, Skolnick, and Cannon-Albright, “Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus,”Nature Gentics, 8:22-26, Sep., 1994.
Kamb, Gruis, Weaver-Feldhaus, Liu, Harshman, Tavtigian, Stockert, Day III, Johnson, and Skolnick, “A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types, ”Science, 264:436-440, Apr., 1994.
Lukeis, Irving, Garson, and Hasthorpe, “Cytogenetics of Non-Small Lung Cancer: Analysis of Consistent Non-Random Abnormalities,”Genes, Chromosomes&Cancer, 2:116-124, 1990.
Mori, Miura, Aoki, Nishihira, Mori, and Nakamura, “Frequent Somatic Mutation of the MTS1/CDK4I (Multiple Tumor Suppressor/Cyclin-dependent Kinase 4 Inhibitor) Gene in Esophageal Squamous Cell Carcinoma,”Cancer Research, 54:3396-3397, Jul., 1994.
Nobori, Szinai, Amox, Parker, Olopade, Buchhagen, and Carson, “Methylthioadenosine Phosphorylase Deficiency in Human Non-Small Cell Lung Cancers,”Cancer Research, 53:1098-1101, Mar., 1993.
Nobori, Miura, Wu, Lois, Takabayashi, and Carson, “Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers,”Nature, 368:753-756, Apr., 1994.
Nobori, Karras, Ragione, Waltz, Chen, and Carson, “Absence of Methylthioadenosine Phosphorylase in Huma Gliomas,”Cancer Research, 51:3193-3197, Jun., 1991.
Olopade, Bohlander, Pomykala, Maltepe, Van Melle, Le Beau, and Diaz, “Mapping of the Shortest Region of Overlap of Deletions of the Short Arm of Chromosome 9 Associated with Human Neoplasia,”Genomics, 14:437-443, 1992.
Olopade, Jenkins, Ransom, Malik, Pomykala, Nobori, Cowan, Rowley, and Diaz, “Molecular Analysis of Deletions of the Short Arm of Chromosome 9 in Human Gliomas,”Cancer Research, 52:2523-2529, May, 1992.
Olopade, Buchhagen, Malik, Sherman, Nobori, Bader, Nau, Gazear, Minna, and Diaz, “Homozygous Loss of the Interferon Genes Defines the Critical Region on 9p That Is Deleted in Lung Cancers,”Cancer Research, 53:2410-2415, May, 1993.
Olopade, Pomykala, Hagons, Sveen, Espinosa III, Dreyling, Gursky, Stadler, Le Beau, and Bohlander, “Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21,”Proc. Natl. Acad. Sci. USA, 92:6489-6493, Jul., 1995.
Olopade, Ransom, Kimmel, Rowley, Diaz, and Jenkins, “Clinical Significance of Loss of the Interferon Genes in Gliomas,”Proceedings of ASCO(Abstract), 10:80, Mar., 1991.
Porterfield, Pomykala, Maltepe, Bohlander, Rowley, and Diaz, “The Use of Methylthioadenosine Phosphorylase Activity to Select for Human Chromosome 9 in Interspecies and Intraspecies Hybrid Cells,”Somatic Cell and Molecular Genetics, 19(5):469-477, 1993.
Porterfield, Diaz, Rowley, and Olopade, “Induction of senescence in two human neoplastic cell lines by microcell transfer of human chromosome 9,”Proceedings of The American Association for Cancer Research(Abstract), 33:73, Mar., 1992.
Porterfield, Olopade, Rowley, and Diaz, “Analysis of Tumor Suppressor Gene on Human Chromosome 9 in Mouse × Human Somatic Cell Hybrids,”Somatic Cell and Molecular Genetics, 20(5):391-400, 1994.
Povey, Armour, Farndon, Haines, Knowles, Olopade, Pilz, White, and Kwiatkowski, “REPORT on the Third International Workshop on Chromosome 9 held at Queen's College, Cambridge, UK, Apr. 9-11, 1994,”Ann. Hum. Genet. (Great Britain), 58:177-250, 1994.
Quesnel, Preudhomme, Philippe, Vanrumbeke, Dervite, Lai, Bauters, Wattel, and Fenaux, “p16 Gene Homozygous Deletions in Acute Lymphoblastic Leukemia,”Blood, 85(3):657-663, Feb., 1995.
Schmidt, Ichimura, Reifenberger, and Collins, “CDKN2 (p16/MTS1) Gene Deletion or CDK4 Amplification Occurs in the Majority of Glioblastomas,”Cancer Research, 54:6321-6324, Dec., 1994.
Serrano, Gomez-Lahoz, DePinho, Beach, and Bar-Sagi, “Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16INK4,”Science, 267:249-252, Jan., 1995.
Serrano, Hannon, and Beach, “A new regulatory motif in cell-cycle control causing specific inhibitoin of cyclin D/CDK4,”Nature, 366:704-707, Dec., 1993.
Thompson, Anderson, Prosser, Chetty, Carter, Evans, and Steel, “p53 Allele Losses, Mutations and Expression in Breast Cancer and Their Relationship to Clinico-Pathological Parameters,”Int. J. Cancer, 50:528-532, 1992.
Vogelstein, Fearon, Stanley, Hamilgon, Scott, Kern, Preisinger, Leppert, Nakamura, White, Smits, and Bos, “Genetic Alterations During Colorectal-Tumor Development,”The New England Journal of Medicine, 319(9):525-5
Arch Development Corporation
Fulbright & Jaworski L.L.P.
Goldberg Jeanine
Jones W. Gary
LandOfFree
Methylthioadenosine phosphorylase compositions and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methylthioadenosine phosphorylase compositions and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylthioadenosine phosphorylase compositions and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3431930